Manufacturing, latest filing in August 2026

On August 27, 2026, the Board of Directors (the "Board") of Applied Materials, Inc. ("Applied" or the "Company") elected Akash Palkhiwala to the Board and the Board's Audit Committee, effective immediately.

Also stated in this filing

• The restricted stock units are scheduled to vest in full on March 1, 2027, subject to Mr. Palkhiwala's continued service as a director through that date.
• Mr. Palkhiwala will enter into the Company's standard form of directors' indemnification agreement with Applied, pursuant to which the Company agrees to indemnify its directors to the fullest extent permitted by applicable law and subject to certain conditions to advance expenses in connection with proceedings as described in the indemnification agreement.

On August 18, 2026, Charles Swanton resigned as a Class II director of the Board of Directors (the "Board") of Bicycle Therapeutics plc (the "Company"), as a member of the Board's committees and as a member of the Company's Clinical Advisory Board, effective immediately.

Also stated in this filing

• Dr. Swanton's resignation was for personal reasons and not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

Effective August 10, 2026, Mr. Eric Hanson, President and Chief Operating Officer, departed from Celsius Holdings, Inc. (the "Company").

Also stated in this filing

• Mr. Hanson is eligible to receive severance benefits under the Company's Executive Severance Pay Plan in connection with his departure from the Company, subject to certain conditions of the plan.

On April 27, 2026 (the "Transition Date"), Giovanni Barbarossa notified Coherent Corp. (the "Company") of his intention to transition from his role as the Company's Chief Strategy Officer, effective as of the Transition Date, and retire in September 2026.

In connection with this transition, Dr. Barbarossa will serve as a Special Advisor to the Chief Executive Officer, effective as of the Transition Date and through the date of his retirement, which will be determined at a later time.

On August 25, 2026, James L. Cunniff, President and Chief Executive Officer of the Company, notified the Company of his intention to retire from the Company effective on or about April 2, 2027.

Also stated in this filing

• The Board of Directors of the Company (the "Board") has engaged an executive search firm and is commencing a comprehensive search to identify the Company's next Chief Executive Officer.
• Mr. Cunniff is also expected to resign from the Board upon his retirement.

On July 14, 2026, Lawrence G. Finch notified Everspin Technologies, Inc. (the "Company") of his resignation from the Company's board of directors (the "Board"), including as a member of the Board's audit committee, effective August 4, 2026.

Also stated in this filing

• Mr. Finch's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
• The Company thanks Mr. Finch for his dedication and years of service to the Company.

Effective as of August 14, 2026, Mr. James Liao resigned from his position as Chief Technology Officer of Foxx Development Holdings Inc. (the "Company").

Also stated in this filing

• Mr. Liao also resigned from his position as Chief Technology Officer of Foxx Development Inc., the Company's operating subsidiary.

Effective August 14, 2026, Brian Tratt was promoted to Senior Vice President, Chief Financial Officer of GoPro, Inc. (the "Company").

Also stated in this filing

• Mr. Tratt previously served as Vice President, Chief Financial Officer.
• In connection with Mr. Tratt's promotion, his annual base salary was increased from $385,000 to $420,000, and his annual discretionary bonus target was increased from 60% to 75%.

On August 19, 2026, the board of governors of Highwater Ethanol, LLC (the "Board") appointed Michael D. Stein to fill a vacancy on the Board.

Also stated in this filing

• Mr. Stein will serve for the unexpired term of his predecessor or until 2029.
• Mr. Stein has been appointed to serve on the risk management, audit and fixed assets committees.

On July 27, 2026, William Garth resigned from his position on the Board of Governors of Highwater Ethanol, LLC (the "Company") effective the same date.

Also stated in this filing

• Mr. Garth did not resign his position because of a disagreement with the Company.

On April 16, 2026, the Company's board of directors (the "Board") appointed Robert D. Lister, the Company's Chief Legal Officer and Senior Executive Vice President, to serve as the Company's interim principal executive officer ("PEO") in addition to his current duties until May 1, 2026, following which Mr. Gelfond will resume the role of PEO.

Also stated in this filing

• As previously announced on March 30, 2026, Richard Gelfond, the Chief Executive Officer of IMAX Corporation (the "Company"), is on a temporary medical leave of absence.
• Mr. Lister will not receive any additional compensation in connection with his temporary interim appointment.

(b) On August 11, 2026, Brian Yoor notified iRhythm Holdings, Inc. (the "Company") of his decision to resign from his position as a member of the Board of Directors of the Company (the "Board") and as a member and chair of the Audit Committee of the Board (the "Audit Committee"), effective August 12, 2026.

Also stated in this filing

• Mr. Yoor's resignation from the Board was for personal reasons and not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
• The Board has appointed Karen McGinnis, a member of the Board and Audit Committee, as chair of the Audit Committee, effective August 12, 2026.

On August 11, 2026, Scott Frisch notified Longevity Health Holdings, Inc. (the "Company") of his resignation from the Board of Directors of the Company, effective as of the close of business on August 11, 2026.

Also stated in this filing

• Mr. Frisch's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

On June 1, 2026, Kathryn Gregory notified Longevity Health Holdings, Inc. (the "Company") of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026.

Also stated in this filing

• Ms. Gregory's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

On August 6, 2026, Mr. Gary S. Gladstein notified the Board of Directors (the "Board") of Mueller Industries, Inc. (the "Company") that he will retire from the Board effective December 31, 2026.

Also stated in this filing

• Mr. Gladstein previously served as a member of the Board from 1990 to 1994 and then rejoined the Board in 2000.
• He later held the positions of Chairman of the Board from 2013 to 2015 and Lead Independent Director from 2016 to 2018.

(d) On August 3, 2026, the Board of Directors (the "Board") of NETGEAR elected Douglas Murray to serve as a member of the Board, effective immediately.

Also stated in this filing

• The Board has not yet determined Mr. Murray's committee assignment.
• NETGEAR and Mr. Murray also entered into NETGEAR's standard Indemnification Agreement for directors.

(b) On April 12, 2026, Bradley L. Maiorino, a member of the Board of Directors (the "Board") of NETGEAR, Inc. (the "Company"), informed the Company that he will not stand for re-election at the upcoming 2026 Annual Meeting of Stockholders (Annual Meeting).

Also stated in this filing

• Mr. Maiorino's decision was made solely due to increased demands from his new full-time executive role and is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
• Mr. Maiorino will continue to serve as a director, Chair of the Company's Cybersecurity Committee (the "Cybersecurity Committee"), and member of the Company's Audit Committee (the "Audit Committee") until the Annual Meeting.
• The Board will appoint Directors to replace his Committee seats and post them on the Company's Committee Governance website before the date of the Annual Meeting.
• The Company thanks Mr. Maiorino for his 8 years of service and dedication to the Company and its stockholders.

Interim Chief Medical Officer On August 18, 2026, the Board of Directors of Tonix Pharmaceuticals Holding Corp. (the "Company") appointed Dr. Seth Lederman, the Company's President and Chief Executive Officer, as the Company's Interim Chief Medical Officer.

Also stated in this filing

• Dr. Lederman, age 69, has been the Company's President, Chief Executive Officer and Chairman of the Board since October 2011, and will continue to serve in these roles.

On July 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the "Company") that he will retire from his role as Chief Medical Officer of the Company, effective August 20, 2026.